Study on the characteristics of immune cell infiltration and its correlation with prognosis in patients with stage III B - IV lung adenocarcinoma by PET-CT based on the theory of 'protecting field' of traditional Chinese Medicine

Dongfang Hospital of Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Patients with lung adenocarcinoma confirmed by histopathology and / or cytology;
•2. Patients who were classified as stage III B - IV according to the 7th edition of TNM staging system published by IASLC;
•3. According to the NCCN guidelines for non-small cell lung cancer (NSCLC), the first-line treatment was carried out according to the recist1.1 evaluation standard for solid tumors;
•4. Patients with at least one cold ablation lesion;
•5. EGFR mutation (-), ALK rearrangement (-);
•6. The patients who refused chemotherapy and radiotherapy in recent 1 month planned to receive systemic therapy (oral Chinese Medicine) + local treatment (target lesion biopsy + cold ablation);
•7. ECOG PS <= 2
•8. Patients whose expected survival time was more than 3 months;
•9. Patients with TCM syndrome conforming to any of the five syndromes of lung cancer;
•10. Patients who voluntarily participated in the study and signed informed consent.

•1. Patients with multiple primary tumors;
•2. Patients with other conditions not suitable for biopsy and cold ablation;
•3. Patients with cold ablation lesions who have received other local minimally invasive treatment, such as radiotherapy, radiofrequency, seed implantation, etc.

发起方

Dongfang Hospital of Beijing University of Chinese Medicine